November 2023 FDA Recall Drug by Insight Pharmaceuticals Corporation
D-0151-2024 - Chemical Contamination; presence of benzene.
This Class I drug recall was voluntarily initiated by Insight Pharmaceuticals Corporation on November 22, 2023 for the product Drug. The FDA reported the reason for recall as chemical contamination; presence of benzene.. The product was distributed Nationwide and the recall is currently completed.
Recall Number: D-0151-2024
Chemical Contamination; presence of benzene.
11-22-2023
12-27-2023
117,336 cans
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Completed
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Insight Pharmaceuticals Corporation
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide and Puerto Rico
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591, UPC 363736532611.
Batch or Lot Expiration Information
Lot# s: 0H88645, Exp 07/31/2024; 0B88345, Exp 02/29/2024.
